Cyclops®

PureIMS secures a European grant to develop a new dry powder inhaler

Category: Status update

PureIMS secures a European grant to develop a new dry powder inhaler

PureIMS secures a European grant to develop a new dry powder inhaler

  PureIMS receives a grant of € 41.028,58 to initiate the development of a new dry powder inhaler (DPI). This new DPI will contain an innovative dispersion mechanism to enable delivery of medicines such as antibiotics, vaccines, and biologics. Unlike current devices, it will be user-friendly and suitable for vulnerable groups like children and elderly […]

PureIMS winning the LIFE Science Innovation Award!

PureIMS winning the LIFE Science Innovation Award!

Tuesday September 26 was an exciting day for the PureIMS team. Not only was the first cohort of volunteers dosed in the penultimate Levodopa Cyclops™ bioavailability study, we were also honored with the LIFE Science Innovation Award. LIFE Cooperative, very successfully organizing their annual conference and award ceremony, is a cooperation of 50+ LifeScience and MedTech SMEs […]